Mckesson (MCK) Income from Continuing Operations (2009 - 2026)
Mckesson (MCK) reported Income from Continuing Operations of 1855000000.0 for Q1 2026, up 42.04% year-over-year from 1306000000.0 in Q1 2025, and up 48.4% quarter-over-quarter from 1250000000.0 in Q4 2025.
Mckesson (MCK) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Income from Continuing Operations data on file, last reported at 1855000000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 1855000000.0, up 42.04% year-over-year; the trailing twelve-month figure through Mar 2026 was 5099000000.0 (up 46.48% YoY), and the FY2026 annual result was 5099000000.0, up 46.48% from the prior year.
- Income from Continuing Operations improved to 1855000000.0 in Q1 2026 per MCK's latest filing, from 1250000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1855000000.0 in Q1 2026 and troughed at 287000000.0 in Q3 2024.
- A 5-year average of 933647058.82 and a median of 928000000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations surged 2769.23% in 2022, then sank 59.17% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 1119000000.0 in 2022, then plunged by 43.7% to 630000000.0 in 2023, then soared by 47.3% to 928000000.0 in 2024, then soared by 34.7% to 1250000000.0 in 2025, then surged by 48.4% to 1855000000.0 in 2026.
- Business Quant data shows MCK's Income from Continuing Operations at 1855000000.0 in Q1 2026, 1250000000.0 in Q4 2025, and 1163000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 1.86 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 380.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 112.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -6.47 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -9.08 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -931,665.81 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.81 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 831.00 Mn |
| Mar 31, 2025 | 1.31 Bn |
| Dec 31, 2024 | 928.00 Mn |
| Sep 30, 2024 | 287.00 Mn |
| Jun 30, 2024 | 960.00 Mn |
| Mar 31, 2024 | 830.00 Mn |
| Dec 31, 2023 | 630.00 Mn |
| Sep 30, 2023 | 703.00 Mn |
| Jun 30, 2023 | 997.00 Mn |
| Mar 31, 2023 | 826.00 Mn |
| Dec 31, 2022 | 1.12 Bn |
| Sep 30, 2022 | 973.00 Mn |
| Jun 30, 2022 | 807.00 Mn |
| Mar 31, 2022 | 407.00 Mn |
| Dec 31, 2021 | 39.00 Mn |
| Sep 30, 2021 | 310.00 Mn |
| Jun 30, 2021 | 536.00 Mn |